Biochip: Small design, huge effects. In any of the four chambers, different conditions can be created.
The initiative brings together research and industry on the topic of microfluidics, lab-on-a-chip and organ-on-a-chip technologies. To bring together relevant engineering, analytical and biomedical expertise in Austria and bridge existing 'research-to-product gaps' in microfluidics, lab-on-a-chip systems and organ-on-a-chip technology ' that is what the Austrian Microfluidics Initiative (AMI), launched by TU Wien in 2017, is aiming at. The initiative is supported by BioNanoNet, its strategic positioning is implemented by Austrian universities and industrial partners. The spokesperson for the Austrian Microfluidics Initiative is Prof. Peter Ertl, also of TU Wien. Exchange ' implementation - support - The Austrian Microfluidics Initiative envisions becoming the partner of choice in all aspects of microfluidic project research and development, thus providing the scientific community and industry with a common platform for: (a) direct technological exchange, - (b) rapid implementation of project ideas - (c) continuous support opportunities. The mission of the Austrian Microfluidics Initiative is to provide technological expertise and know-how ranging from microfluidics design and simulation, and rapid prototyping and assay miniaturization to small and large-scale production of microdevices with the aim of: (1) promoting scientific collaboration between industry and academia - (2) supporting technology transfer activities - (3) offering education and training. The main objective of the Initiative is to turn research ideas into functional prototypes and the realization of successful commercial products by reducing development cost and timelines.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
